Dr. Frank Mathias in an interview with the German edition "Biotechnology 2022" of GoingPublic
Ready to take off: Opportunities for developers and manufacturers in cell and gene therapy
We believe that revolutionary ideas come to life when they have the space to develop.
The unique feature of our client dialogue is actually quite simple: We are listening.
Our secret: We find solutions where others do not even look.
Our track record: Security for our clients. Guidepost for our future.
As a leading CDMO, we develop and manufacture biopharmaceuticals and support you with the creation of approval documents at an international level. We are a specialist for mammalian expression. Many years of experience and excellence in finding solutions as well as certified quality management and advanced technologies ensure Rentschler Biopharma’s high quality standards. With our full-service offering, we are your partner of choice.